Thus, substantial effort is being directed to the search for additional protein biomarkers which either individually or in combination with CA125 and other markers could enhance the sensitivity and specificity for detecting ovarian cancer at an earlier, more treatable stage. The gene discussed is MUC16; the disease is ovarian cancer.